Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MGEN

Miragen Therapeutics (MGEN) Stock Price, News & Analysis

Miragen Therapeutics logo

About Miragen Therapeutics Stock (NASDAQ:MGEN)

Advanced Chart

Key Stats

Today's Range
$13.92
$14.71
50-Day Range
$14.34
$23.01
52-Week Range
$4.66
$34.05
Volume
470,330 shs
Average Volume
134,027 shs
Market Capitalization
$54.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Miragen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MGEN Stock News Headlines

Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
Viridian Therapeutics Inc (VRDN)
See More Headlines

MGEN Stock Analysis - Frequently Asked Questions

Miragen Therapeutics, Inc. (NASDAQ:MGEN) issued its quarterly earnings data on Tuesday, November, 10th. The medical research company reported ($0.10) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.13) by $0.03. Miragen Therapeutics had a negative net margin of 1,393.50% and a negative trailing twelve-month return on equity of 141.66%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Miragen Therapeutics investors own include Sorrento Therapeutics (SRNE), OPKO Health (OPK), Nokia (NOK), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX) and Pfizer (PFE).

Company Calendar

Last Earnings
11/10/2020
Today
7/01/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:MGEN
Fax
N/A
Employees
45
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$41.87 million
Net Margins
-1,393.50%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.46 million
Price / Cash Flow
N/A
Book Value
$6.78 per share
Price / Book
2.06

Miscellaneous

Free Float
N/A
Market Cap
$54.63 million
Optionable
Not Optionable
Beta
1.66
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:MGEN) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners